3140 results for «238»
3140 results
Intermediate risk TAVI
23 May 2019 – From EuroPCR 2019
Opening - LIVE demonstration from National University Heart Centre Singapore
04 Jul 2019 – From AICT-AsiaPCR 2019
Complex distal left main bifurcation lesion
04 Jul 2019 – From AICT-AsiaPCR 2019
A 75-year-old male with multiple risk factors and a history of NSTEMI is admitted for staged PCI to his left main bifurcation. His vessels are diffusely calcified…
Calcified lesions
05 Jul 2019 – From AICT-AsiaPCR 2019
Watch this LIVE demonstration from National University Heart Centre (Singapore) to discover how they managed the case of a 69 years-old male with diabetes, hypertension and hyperlipidemia suffering from a calcified triple vessel disease.
Diffuse multivessel disease
05 Jul 2019 – From AICT-AsiaPCR 2019
TAVI in a bicuspid aortic valve stenosis
05 Jul 2019 – From AICT-AsiaPCR 2019
Watch this LIVE demonstration from Clinique Pasteur (France) to learn about the case of a 81 years-old male patient with dyslipidemia referred to the hospital because of NYHA II shortness of breath related to a severe aortic stenosis. CT scan revealed a type I L-R bicuspid...
LAD/D1 bifurcation disease
06 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to discover the key clinical data and angiographic reference of a patient presenting with LAD/D1 bifurcation disease.
A patient with LAD-diagonal bifurcation lesion
22 May 2019 – From EuroPCR 2019
PCR London Valves Opening Ceremony
18 Nov 2019 – From PCR London Valves 2019
Consult this session on PCR London Valves, a patient-oriented course for all of the heart valve team, to discover the 2019 Opening Ceremony, led by Jean Fajadet: learn all about the course program, and how it will enhance your clinical practice.
PCR London Valves Closing Ceremony
19 Nov 2019 – From PCR London Valves 2019
Consult this session to discover PCR London Valves 2019 Closing Ceremony, which gathered over 3000 participants, and learn all about the key moments and what makes this course a wonderful opportunity to enhance your knowledge on transcatheter therapies for valvular heart disease.
Transcatheter edge-to-edge repair for secondary mitral regurgitation - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from Clinique Pasteur - Toulouse, France
TAVI for a patient with severe aortic stenosis and a mechanical mitral prosthesis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
View this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
TAV in TAV for an 8-year old degenerating TAVI device - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
TAVI device selection for severe aortic stenosis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from University Hospital of Zurich (Zurich, Switzerland) to learn more about TAVI device selection and « Best practice » implantation of the Portico Valve.
TAVI in bicuspid aortic valve disease - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with LIVE demonstration from Clinique Pasteur - Toulouse, France
Transcatheter mitral valve-in-valve for a patient with a degenerating bioprosthesis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial
09 Nov 2022
Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.
Author
